Foundations strengthened at medical tests developer as revenues climb
Abingdon Health, a developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, has flagged up a 31 per cent rise in full year revenues.
In a trading update for the financial year ended 30 June 2026, the York-based business highlights strong growth in H2 and total revenue - including grant-funded income - for FY 26 expected to increase to £11.3m (FY 25: £8.6m).
The firm says its H2 performance was driven by significant growth in Contract Development (R&D) revenues.
Dr Chris Hand, exe... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
